The Pirbright Institute
-
Study sheds light on Crimean-Congo haemorrhagic fever risks in livestock
The Crimean-Congo haemorrhagic fever virus is also endemic in Africa and has case fatality rate of 40%.
-
Pirbright, GALVmed partner to develop new Rift Valley fever vaccine
The Pirbright Institute is a world-leading research and surveillance center for viral diseases of livestock and viruses that spread from animals to humans.
-
UK partnership to drive RNA vaccine development for livestock
In related developments, researchers at the Massachusetts Institute of Technology (MIT) are working on an mRNA-based vaccine for African swine fever (ASF) that could be more effective than conventional vaccines.
-
CRISPR-edited chicken cells boost virus yields for poultry vaccines
Currently, most poultry vaccines are produced using embryonated chicken eggs (ECE), a system burdened by high costs, ethical concerns, and supply chain vulnerabilities.
-
The Vaccine Group’s ASF vaccine candidate begins animal trials at Pirbright
Pigs have already been vaccinated and will be challenged with a virulent strain of the ASF virus to assess the vaccine’s efficacy.
-
Veterinary vaccine innovation centre breaks ground at Pirbright to tackle global animal health threats
Its mission is to accelerate vaccine innovation for diseases often overlooked by mainstream pharmaceutical companies.
